How to follow up advanced-stage borderline tumours? Mode of diagnosis of recurrence in a large series stage II-III serous borderline tumours of the ovary

Annals of Oncology

Volumn 22, Issue 3, 2011, Pages 631-635

  Uzan, C ^a   Kane, A ^a   Rey, A ^a   Gouy, S ^a   Pautier, P ^a   Lhomme, C ^a   Duvillard, P ^a   Morice, P ^a,b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Borderline tumour; CA 125; Follow up; Implant; Recurrence; Ultrasound

Indexed keywords

CA 125 ANTIGEN; CA 19-9 ANTIGEN;

ADVANCED CANCER; ANTIGEN DETECTION; ARTICLE; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; ECHOGRAPHY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY TUMOR; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECURRENT CANCER;

EID: 79952011817     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq414     Document Type: Article

References (22)

1. Taylor HC. Malignant and semi-malignant tumors of the ovary. Surg Gynecol Obstet 1929; 48: 204-230.
2. Morice P. Borderline tumours of the ovary and fertility. Eur J Cancer 2006; 42: 149-158.
3. Tinelli R, Tinelli A, Tinelli FG et al. Conservative surgery for borderline ovarian tumors: a review. Gynecol Oncol 2006; 100: 185-191.
4. Borgfeldt C, Iosif C, Måsbäck A. Fertility-sparing surgery and outcome in fertile women with ovarian borderline tumors and epithelial invasive ovarian cancer. Eur J Obstet Gynecol Reprod Biol 2007; 134: 110-114.
5. Duvillard P. Tumeurs ovariennes à la limite de la malignité. Ann Pathol 1996; 16: 396-405.
6. Seidman JD, Kurman RJ. Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases. Am J Surg Pathol 1996; 20: 1331-1345.
7. Eichhorn JH, Bell DA, Young RH, Scully RE. Ovarian serous borderline tumors with micropapillary and cribriform patterns: a study of 40 cases and comparison with 44 cases without these patterns. Am J Surg Pathol 1999; 23: 397-409.
8. International Federation of Gynecology and Obstetrics. Changes in definitions of clinical staging for carcinoma of the cervix and ovary. Am J Obstet Gynecol 1987; 156: 263-264.
9. Bell DA, Scully RE. Serous borderline tumors of the peritoneum. Am J Surg Pathol 1990; 14: 230-239.
10. Bell DA, Weinstock MA, Scully RE. Peritoneal implants of ovarian serous borderline tumors. Histologic features and prognosis. Cancer 1988; 62: 2212-2222.
11. Kane A, Uzan C, Rey A et al. Prognostic factors in patients with ovarian serous low malignant potential (borderline) tumors with peritoneal implants. Oncologist 2009; 14: 591-600.
12. Gershenson D, Silva E, Levy L et al. Ovarian serous borderline tumors with invasive peritoneal implants. Cancer 1998; 82: 1096-1103.
13. Zanetta G, Rota S, Chiari S et al. Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study. J Clin Oncol 2001; 19: 2656-2664.
14. Zanetta G, Rota S, Lissoni A et al. Ultrasound, physical examination, and CA 125 measurement for the detection of recurrence after conservative surgery for early borderline ovarian tumors. Gynecol Oncol 2001; 81: 63-66.
15. Prat J, de Nictolis M. Serous borderline tumors of the ovary. A long-term followup study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion. Am J Surg Pathol 2002; 26: 1111-1128.
16. Gilks CB, Alkushi A, Yue JJW et al. Advanced-stage serous borderline tumors of the ovary: a clinicopathological study of 49 cases. Int J Gynecol Pathol 2002; 22: 29-36.
17. Deavers MT, Gershenson DM, Tortolero-Luna G et al. Micropapillary and cribriform patterns in ovarian serous tumors of low malignant potential: a study of 99 advanced stage cases. Am J Surg Pathol 2002; 26: 1129-1141.
18. Longacre TA, McKenney JK, Tazelaar HD et al. Ovarian serous tumors of low malignant potential (borderline tumors). Outcome-based study of 276 patients with long-term (> 5-year) follow up. Am J Surg Pathol 2005; 29: 707-723.
19. Silva EG, Gershenson DM, Malpica A, Deavers M. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent. Am J Surg Pathol 2006; 30: 1367-1371.
20. Ren J, Peng Z, Yang K. A clinicopathologic multivariate analysis affecting recurrence of borderline ovarian tumors. Gynecol Oncol 2008; 110: 162-167.
21. Lenhard MS, Mitterer S, Kümper C et al. Long-term follow-up after ovarian borderline tumor: relapse and survival in a large patient cohort. Eur J Obstet Gynecol Reprod Biol 2009; 145: 189-194.
22. Rustin GJ, van der Burg ME; on behalf of MRC and EORTC collaborators. A randomized trial in ovarian cancer (OC) of early treatment of relapse based on CA125 level alone versus delayed treatment based on conventional clinical indicators (MRC OV05/EORTC 55955 trials). J Clin Oncol 2009; 27: 18 (Suppl; Abstr 1).